UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000046411
Receipt number R000052955
Scientific Title The clinical factors of acute abdominal symptom induced by gastric anisakiasis
Date of disclosure of the study information 2021/12/22
Last modified on 2023/09/24 12:38:06

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The clinical factors of acute abdominal symptom induced by gastric anisakiasis

Acronym

The clinical factors of acute abdominal symptom induced by gastric anisakiasis

Scientific Title

The clinical factors of acute abdominal symptom induced by gastric anisakiasis

Scientific Title:Acronym

The clinical factors of acute abdominal symptom induced by gastric anisakiasis

Region

Japan


Condition

Condition

gastric anisakiasis

Classification by specialty

Gastroenterology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The purpose of this study is to analyze cases diagnosed with gastric anisakiasis and to examine clinical factors involved in the appearance of symptoms.

Basic objectives2

Others

Basic objectives -Others

Clinical factors

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Analyzing clinical factors in symptomatic and asymptomatic cases of gastric anisakiasis

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients diagnosed with gastric anisakiasis by upper gastrointestinal endoscopy

Key exclusion criteria

(1) Patients whose background gastric mucosa cannot be evaluated.
(2) Patients who have stated refusal to use clinical data.

Target sample size

260


Research contact person

Name of lead principal investigator

1st name Tetsuya
Middle name
Last name Sumiyoshi

Organization

Tonan Hospital

Division name

Gastroenterology

Zip code

060-0004

Address

North 4, West 7, chuo-ku, Sapporo, Hokkaido, Japan

TEL

0112312121

Email

t-sumiyoshi@tonan.gr.jp


Public contact

Name of contact person

1st name Yusuke
Middle name
Last name Tomita

Organization

Tonan Hospital

Division name

Gastroenterology

Zip code

060-0004

Address

North 4, West 7, chuo-ku, Sapporo, Hokkaido, Japan

TEL

0112312121

Homepage URL


Email

yusuke.tomita@tonan.gr.jp


Sponsor or person

Institute

Tonan Hospital

Institute

Department

Personal name



Funding Source

Organization

none

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Tonan Hospital

Address

North 4, West 7, chuo-ku, Sapporo, Hokkaido, Japan

Tel

0112312121

Email

tonanhsp@tonan.gr.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2021 Year 12 Month 22 Day


Related information

URL releasing protocol


Publication of results

Published


Result

URL related to results and publications


Number of participants that the trial has enrolled

264

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2021 Year 09 Month 15 Day

Date of IRB

2021 Year 11 Month 12 Day

Anticipated trial start date

2021 Year 11 Month 24 Day

Last follow-up date

2022 Year 10 Month 01 Day

Date of closure to data entry

2022 Year 10 Month 01 Day

Date trial data considered complete

2022 Year 10 Month 01 Day

Date analysis concluded

2022 Year 10 Month 01 Day


Other

Other related information

none


Management information

Registered date

2021 Year 12 Month 18 Day

Last modified on

2023 Year 09 Month 24 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000052955